Intra-Cellular Therapies Inc. buy JPMorgan Chase & Co.
Start price
04.11.24
/
50%
€80.00
Target price
04.11.25
€81.61
Performance (%)
53.75%
End price
05.11.25
-
Summary
This prediction is currently being closed. The BUY prediction by JPMorgan_Chase___Co_ for Intra-Cellular Therapies Inc. has seen massive gains of 53.75%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at JPMorgan Chase & Co. from $81.00 to $89.00. They now have an "overweight" rating on the stock.
Ratings data for ITCI provided by MarketBeat
In the thread Trading Intra-Cellular Therapies Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by JPMorgan_Chase___Co_ for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.00
21.08.24
21.08.24
€72.78
21.08.25
21.08.25
80.88%
22.08.25
22.08.25
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.00
12.06.24
12.06.24
€72.03
12.06.25
12.06.25
92.19%
13.06.25
13.06.25
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€41.80
09.03.23
09.03.23
€54.81
09.03.24
09.03.24
45.22%
10.03.24
10.03.24